Guardion Health Sciences, Inc. (GHSI) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $3.25. It has a SharesGrow Score of 51/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of GHSI = $170.24 (+5138.2% from the current price, the stock appears undervalued). Analyst consensus target is GHSI = $0 (-99.6% upside).
Valuation: GHSI trades at a trailing Price-to-Earnings (P/E) of 26.1 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.26.
Financials: revenue is $12M, +115.5%/yr average growth. Net income is $158,033, growing at -36.8%/yr. Net profit margin is 1.3% (thin). Gross margin is 44% (+47 pp trend).
Balance sheet: total debt is $0 against $8M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 9.01 (strong liquidity). Debt-to-assets is 0%. Total assets: $12M.
Analyst outlook: 1 / 2 analysts rate GHSI as buy (50%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 70/100 (Pass), Growth 58/100 (Partial), Past 25/100 (Fail), Health 100/100 (Pass), Moat 43/100 (Fail), Future 28/100 (Fail), Income 30/100 (Fail).
